IZZI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 9.002
EU - Europa 682
AS - Asia 239
SA - Sud America 12
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.944
Nazione #
US - Stati Uniti d'America 8.984
IE - Irlanda 192
IT - Italia 140
KR - Corea 107
DE - Germania 103
CN - Cina 97
UA - Ucraina 76
GB - Regno Unito 61
FR - Francia 26
RU - Federazione Russa 20
CA - Canada 17
FI - Finlandia 17
SE - Svezia 15
NL - Olanda 9
BE - Belgio 7
BR - Brasile 6
JP - Giappone 6
SG - Singapore 6
AU - Australia 4
CH - Svizzera 4
IN - India 4
EU - Europa 3
HU - Ungheria 3
AR - Argentina 2
HK - Hong Kong 2
IR - Iran 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PL - Polonia 2
TH - Thailandia 2
AT - Austria 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TR - Turchia 1
TW - Taiwan 1
Totale 9.944
Città #
Wilmington 2.559
Houston 2.454
Woodbridge 1.581
Fairfield 407
Chandler 331
Ashburn 263
Seattle 193
Dublin 165
Cambridge 159
Ann Arbor 149
Medford 115
New York 104
Dearborn 72
Rome 69
Beijing 67
Lawrence 54
Menlo Park 40
San Diego 34
Jacksonville 32
Seoul 15
Redwood City 13
London 12
Norwalk 12
Toronto 12
Kilburn 9
Milan 9
Zhengzhou 8
Brussels 7
Palo Alto 7
Creede 6
Philadelphia 6
San Francisco 6
São Paulo 6
Washington 6
Hounslow 5
Nanjing 5
Amsterdam 4
Boardman 4
Engelhard 4
Kunming 4
Pune 4
Redmond 4
Roebling 4
Verona 4
Atlanta 3
Budapest 3
Chicago 3
Columbus 3
Council Bluffs 3
Florence 3
Huskvarna 3
Islington 3
Nashville 3
Prescot 3
Solofra 3
Tokyo 3
Alderley Edge 2
Apeldoorn 2
Auckland 2
Bangkok 2
Capranica 2
Colombo 2
Dallas 2
Doganella 2
Enfield 2
Helsinki 2
Kraków 2
La Veta 2
Lappeenranta 2
Las Vegas 2
Lima 2
Lucca 2
Manila 2
Mountain View 2
Nanchang 2
New Bedfont 2
Palermo 2
Phoenix 2
Pisa 2
Rozzano 2
Saint Petersburg 2
Salt Lake City 2
San Jose 2
San Mateo 2
Sant'Angelo dei Lombardi 2
Singapore 2
Southwark 2
Thornhill 2
Yreka 2
Adliswil 1
Almaty 1
Andover 1
Ashdod 1
Athens 1
Augusta 1
Bari 1
Baulkham Hills 1
Camden 1
Canberra 1
Colorado Springs 1
Totale 9.137
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 445
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 443
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 432
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 401
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 401
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 386
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 383
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 373
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 352
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 342
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 335
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 334
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 333
Obstructive sleep apnoea and bone health 309
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 305
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 293
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 257
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 238
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 207
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 185
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 185
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 177
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 175
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 174
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 172
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 171
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording 171
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 166
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 160
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 149
Seasonality of restless legs syndrome: symptom variability in winter and summer times 144
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 140
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies 138
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 132
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 127
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 108
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 104
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 95
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 58
Heart Rate Variability Parameters During Psychogenic Non-epileptic Seizures: Comparison Between Patients With Pure PNES and Comorbid Epilepsy 52
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 47
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 47
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 46
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 42
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 37
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 36
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 33
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 32
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 29
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 27
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 26
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 26
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 24
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 22
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 21
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 18
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 17
Brivaracetam as early add-on treatment in patients with focal seizures: a retrospective, multicenter, real-world study 15
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 15
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 15
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 14
Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance 13
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 10
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 10
Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease 7
Brainstem impairment in obstructive sleep apnoea and the effect of CPAP treatment: an electrophysiological blink reflex study 7
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 4
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 3
Totale 10.195
Categoria #
all - tutte 25.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019638 0 0 0 0 0 0 0 0 0 207 214 217
2019/20202.981 176 165 128 214 200 229 214 389 373 351 282 260
2020/20212.411 282 280 265 289 236 300 295 224 43 106 68 23
2021/2022661 27 46 26 11 16 18 65 15 33 53 40 311
2022/2023882 103 77 41 105 73 177 77 60 85 16 37 31
2023/2024396 54 10 25 23 39 158 21 37 8 21 0 0
Totale 10.195